{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:15:52Z","timestamp":1782209752686,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.diagmicrobio.2020.115033","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T12:36:09Z","timestamp":1583843769000},"page":"115033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Performance characteristics of the high sensitivity Alinity i & ARCHITECT HBsAg Next Qualitative\/Confirmatory assays"],"prefix":"10.1016","volume":"97","author":[{"given":"Eva","family":"Sickinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Bertram","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Daghfal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schultess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0005","unstructured":"ARCHITECT HBsAg Qualitative II Package Insert: G3-4444\/R05, 2013."},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0010","unstructured":"Atellica IM Hepatitis B surface Antigen II (HBsII) (Siemens) Package Insert: Rev. 02, 2017-12"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fmed.2018.00029","article-title":"Hepatitis B virus blood screening: need for reappraisal of blood safety measures?","volume":"5","author":"Candotti","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0020","doi-asserted-by":"crossref","first-page":"30009","DOI":"10.2807\/1560-7917.ES.2015.20.35.30009","article-title":"Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013","volume":"20","author":"Coppola","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0025","unstructured":"Elecsys HBsAg II (Roche Cobas) Package Insert: Rev. 2018-06, V 1.0"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0030","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/trf.12653","article-title":"Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors","volume":"54","author":"Enjalbert","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.21037\/aob.2018.09.03","article-title":"Hepatitis B viral safety of blood donations: new gaps identified","volume":"3","author":"Gerlich","year":"2018","journal-title":"Ann blood"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0040","unstructured":"Global Hepatitis Report. 2017. Geneva: World Health Organization; 2017. http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en."},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0045","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00103-016-2333-8","article-title":"Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany","volume":"59","author":"Hampel","year":"2016","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178988","article-title":"Hepatitis B Genotypes and Surface Antigen Mutants Present in Pakistani Blood Donors","author":"Harris","year":"2017","journal-title":"PLOS ONE. Epub"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0055","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/clinids\/20.4.992","article-title":"Risks of chronicity following acute hepatitis B virus infection: a review","volume":"20","author":"Hyams","year":"1995","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0060","first-page":"97","article-title":"Performance characteristics of the ARCHITECT anti-HCV assay","volume":"34","author":"Jonas","year":"2005","journal-title":"JCV"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0065","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/infdis\/jit563","article-title":"Cytokine and chemokine responses in the acute phase of hepatitis B virus replication in na\u00efve and previously vaccinated blood and plasma donors","volume":"209","author":"Keating","year":"2014","journal-title":"JID."},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0070","first-page":"1","article-title":"Improved detection of early acute, late acute, and occult Hepatitis B infections by an increased sensitivity HBsAg assay","volume":"118","author":"Kuhns","year":"2019","journal-title":"JCV"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12985-019-1154-4","article-title":"Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors","volume":"16","author":"Kuhns","year":"2019","journal-title":"Virology Journal"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0080","first-page":"18","article-title":"An ultra-sensitive Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg)","volume":"105","author":"Lou","year":"2018","journal-title":"JCV"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0085","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/j.1537-2995.2011.03553.x","article-title":"Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations","volume":"52","author":"Martin","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0090","first-page":"159","article-title":"Are current screening protocols for chronic hepatitis B virus infection adequate?","volume":"85","author":"Mortensen","year":"2016","journal-title":"DMID"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0095","doi-asserted-by":"crossref","unstructured":"Popp C, Krams D, Beckert C, Buenning C, Queir\u00f3s L, Piro L, Luciani M, Roebbecke M, Kapprell HP. HBsAg blood screening and diagnosis: performance evaluation of the ARCHITECT HBsAg qualitative and ARCHITECT HBsAg qualitative confirmatory assays DMID 2011; 70: 479\u2013485.","DOI":"10.1016\/j.diagmicrobio.2011.03.022"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virol.2017.01.008","article-title":"Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon","volume":"504","author":"Rodgers","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1537-2995.2011.03283.x","article-title":"Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?","volume":"52","author":"Stramer","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1537-2995.2011.03355.x","article-title":"Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk","volume":"52","author":"Vermeulen","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0115","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/trf.12218","article-title":"Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and hepatitis B virus infections","volume":"53","author":"Vermeulen","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0120","author":"WHO Hepatitis B key facts"},{"key":"10.1016\/j.diagmicrobio.2020.115033_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jviromet.2015.11.016","article-title":"The Lumipulse G HBsAg-Quant assay for screening and quantification of the hepatitis B surface antigen","volume":"228","author":"Yang","year":"2016","journal-title":"J. of Virol. Methods"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319312829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319312829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:53:38Z","timestamp":1760003618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889319312829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0732889319312829"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115033","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance characteristics of the high sensitivity Alinity i & ARCHITECT HBsAg Next Qualitative\/Confirmatory assays","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115033"}}